Ad is loading...
FIVCX vs MVCAX
FIVCX vs MVCAX Comparison
Open Charts FIVCX vs MVCAX
Delaware Opportunity C
Price$34.61
Change+$0.28 (+0.82%)
VolumeN/A
CapitalizationN/A
FIVCX vs MVCAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VS
FIVCX vs. MVCAX commentary
Dec 25, 2024
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FIVCX is a Buy and MVCAX is a Buy.
FUNDAMENTALS
Fundamentals
MVCAX pays higher dividends than FIVCX: MVCAX (1.16) vs FIVCX (0.29). FIVCX was incepted earlier than MVCAX: FIVCX (2 years) vs MVCAX (23 years). MVCAX is a more actively managed with annual turnover of: 19.00 vs. FIVCX (11.00). FIVCX (1000) and MVCAX (1000) have matching initial minimum investment requirements. MVCAX annual gain was more profitable for investors over the last year : 4.40 vs. FIVCX (3.36).
| FIVCX | MVCAX | FIVCX / MVCAX | |
| Total Expense Ratio | N/A | N/A | - |
| Annual Report Gross Expense Ratio | N/A | N/A | - |
| Fund Existence | 2 years | 23 years | - |
| Gain YTD | 2.631 | 3.912 | 67% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 1000 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | N/A | 17.1B | - |
| Annual Yield % from dividends | 0.29 | 1.16 | 25% |
| Returns for 1 year | 3.36 | 4.40 | 76% |
| Returns for 3 years | N/A | 1.80 | - |
| Returns for 5 years | N/A | 29.28 | - |
| Returns for 10 years | 157.54 | 63.01 | 250% |
View a ticker or compare two or three
VS
VS
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| RYVYX | 577.64 | 11.23 | +1.98% |
| Rydex NASDAQ-100® 2x Strategy H | |||
| DSMLX | 59.41 | 0.60 | +1.02% |
| Touchstone Large Company Growth Instl | |||
| IPMIX | 21.39 | 0.06 | +0.28% |
| Voya Index Plus MidCap Port I | |||
| BGSIX | 74.15 | N/A | N/A |
| BlackRock Technology Opportunities Instl | |||
| GEMJX | 12.01 | N/A | N/A |
| Goldman Sachs Emerging Mkt Eq ex. ChnIns | |||